Burden of obstructive lung disease study in Tehran: Prevalence and risk factors of chronic obstructive pulmonary disease

Lung India

Volumn 32, Issue 6, 2015, Pages 572-577

  Sharifi, Hooman ^a   Masjedi, Mohammad Reza ^b   Emami, Habib ^a   Ghanei, Mostafa ^c   Eslaminejad, Alireza ^b   Radmand, Golnar ^b   Buist, Sonia ^d  

^a Shahid Beheshti University of Medical Sciences   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Chronic obstructive pulmonary disease; Iran; prevalence

Indexed keywords

SALBUTAMOL;

ADULT; ARTICLE; CHRONIC BRONCHITIS; CHRONIC COUGH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DYSPNEA; EMPHYSEMA; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG BURDEN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREVALENCE; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; SMOKING; SMOKING HABIT; SPIROMETRY; WHEEZING;

EID: 84946018501     PISSN: 09702113     EISSN: 0974598X     Source Type: Journal    
DOI: 10.4103/0970-2113.168129     Document Type: Article

References (31)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-128.
2. Raherison C, Girodet PO. Epidemiology of COPD. Eur Respir Rev 2009;18:213-21.
3. Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M, et al. A 10 year asthma programme in Finland: Major change for the better. Thorax 2006;61:663-70.
4. Balkissoon R, Lommatzsch S, Carolan B, Make B. Chronic obstructive pulmonary disease: A concise review. Med Clin North Am 2011;95:1125-41.
5. Global Initiative for Chronic Obstructive Lung Disease Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease 2013. Available from: http://www.goldcopd.org/uploads/users/files/GOLDlowbar Report2013Feb20.pdf. [Last accessed on 2013 Jul 20].
6. Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, et al.; Committee on Nonsmoking COPD, Environmental and Occupational Health Assembly. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;182:693-718.
7. Lamprecht B, McBurnie MA, Vollmer WM, Gudmundsson G, Welte T, Nizankowska-Mogilnicka E, et al.; BOLD Collaborative Research Group. COPD in never smokers: Results from the population-based burden of obstructive lung disease study. Chest 2011;139:752-63.
8. Hooman S, Zahra H, Safa M, Hassan FM, Reza MM. Association between cigarette smoking and suicide in psychiatric inpatients. Tob Induc Dis 2013;11:5.
9. Amra B, Golshan M, Fietze I, Penzel T, Welte T. Correlation between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome in a general population in Iran. J Res Med Sci 2011;16:885-9.
10. Fukuchi Y, Nishimura M, Ichinose M, Adachi M, Nagai A, Kuriyama T, et al. COPD in Japan: The Nippon COPD epidemiology study. Respirology 2004;9:458-65.
11. Schirnhofer L, Lamprecht B, Vollmer WM, Allison MJ, Studnicka M, Jensen RL, et al. COPD prevalence in Salzburg, Austria: Results from the burden of obstructive lung disease (BOLD) study. Chest 2007;131:29-36.
12. Vollmer WM, Gislason T, Burney P, Enright PL, Gulsvik A, Kocabas A, et al. Comparison of spirometry criteria for the diagnosis of COPD: Results from the BOLD study. Eur Respir J 2009;34:588-97.
13. Gingter C, Wilm S, Abholz HH. Is COPD a rare disease? Prevalence and identification rates in smokers aged 40 years and over within general practice in Germany. Fam Pract 2009;26:3-9.
14. Gershon AS, Wang C, Guan J, Vasilevska-Ristovska J, Cicutto L, To T. Identifying individuals with physcian diagnosed COPD in health administrative databases. COPD 2009;6:388-94.
15. Buist AS, Vollmer WM, Sullivan SD, Weiss KB, Lee TA, Menezes AM, et al. The burden of obstructive lung disease initiative (BOLD): Rationale and design. COPD 2005;2:277-83.
16. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al.; BOLD Collaborative Research Group. International variation in the prevalence of COPD (The BOLD Study): A population-based prevalence study. Lancet 2007;370:741-50.
17. Lundbäck B, Lindberg A, Lindström M, Rönmark E, Jonsson AC, Jönsson E, et al. Obstructive Lung Disease in Northern Sweden Studies. Not 15 but 50% of smokers develop COPD?-Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003;97:115-22.
18. Tzanakis N, Anagnostopoulou U, Filaditaki V, Christaki P, Siafakas N; COPD group of the Hellenic Thoracic Society. Prevalence of COPD in Greece. Chest 2004;125:892-900.
19. Vasankari TM, Impivaara O, Heliövaara M, Heistaro S, Liippo K, Puukka P, et al. No increase in the prevalence of COPD in two decades. Eur Respir J 2010;36:766-73.
20. Soriano JB, Ancochea J, Miravitlles M, García-Río F, Duran-Dauleria E, Muñoz L, et al. Recent trends in COPD prevalence in Spain: A repeated cross-sectional survey 1997-2007. Eur Respir J 2010;36:758-65.
21. The President's Office Deputy of Strategic Planning and Control Statistical Center of Iran. National Population and Housing Census 2011. Available from: http://iran.unfpa.org/Documents/Census2011/2011 Census Selected Results-Eng.pdf.
22. Feenstra TL, van Genugten ML, Hoogenveen RT, Wouters EF, Rutten-van Mölken MP. The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: A model analysis in the Netherlands. Am J Respir Crit Care Med 2001;164:590-6.
23. Varkey AB. Chronic obstructive pulmonary disease in women: Exploring gender differences. Curr Opin Pulm Med 2004;10:98-103.
24. Albers M, Schermer T, Molema J, Kloek C, Akkermans R, Heijdra Y, et al Do family physicians' records fit guideline diagnosed COPD? Fam Pract 2009 26 81-7.
25. Hvidsten SC, Storesund L, Wentzel-Larsen T, Gulsvik A, Lehmann S. Prevalence and predictors of undiagnosed chronic obstructive pulmonary disease in a Norwegian adult general population. Clin Respir J 2010;4:13-21.
26. Robalo Cordeiro C, Singh S, Herth FJ, Ley S, Chavannes NH, Clini E, et al. Selected clinical highlights from the 2010 ERS Congress in Barcelona. Eur Respir J 2011;38:209-17.
27. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: Data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000;160:1683-9.
28. Rennard SI, Vestbo J. Natural histories of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5:878-83.
29. Ferguson GT, Enright PL, Buist AS, Higgins MW. Office Spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. Chest 2000;117:1146-61.
30. Fang X, Wang X, Bai C. COPD in China: The burden and importance of proper management. Chest 2011;139:920-9.
31. Zhang J, Ou JX, Bai CX. Tobacco smoking in China: Prevalence, disease burden, challenges and future strategies. Respirology 2011;16:1165-72.